Where Bioscope.ai's ads lose the buyer

Bioscope.ai is running 3 live ads on LinkedIn and Google. Their average fit to their own ideal buyer is 6.7 out of 10, and 1 ad needs fixing. Each ad below is one of Bioscope.ai’s real live creatives, read straight from the ad libraries.

Bioscope.ai’s live ads, scored against their buyer

• Whole-Genome Clinical AI See Whole Patient, scored 8/10 against Bioscope.ai’s ideal buyer. Sharp ICP match naming genome plus labs plus longevity clinic fit, but no proof or outcome specificity.
• OpenEvidence Alternative Literature Meets Patient Data, scored 7/10 against Bioscope.ai’s ideal buyer. Clever competitor hook targets active searchers but body copy buries the longevity clinic angle.
• Precision Medicine Platform Genome Labs View, scored 5/10 against Bioscope.ai’s ideal buyer. Accurate but generic label with no hook, no outcome, and no reason to click over rivals.

See Bioscope.ai’s full live-ad board on AdRoast. Every creative scored against their ICP, with the exact fix for each.

Learn the method behind these scores: the AdRoast guides cover how to audit your ads against your ICP and why clicks do not turn into pipeline.